Evidence map›Paper›PMID 36440263›Full record

ReviewFrontiers in neuroscience2022

Vascular smooth muscle cell dysfunction in neurodegeneration.

Genevieve Hayes, Joana Pinto, Sierra N Sparks, Congxiyu Wang, Sana Suri, Daniel P Bulte

Abstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. AβInternational journal of molecular sciences · 2025
    Article
  11. Review
  12. Review
  13. Evidence of cortical vascular impairments in early stage of Alzheimer's transgenic mice: Optical imaging.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025
    Article
  14. Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Genevieve HayesDepartment of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom.
Joana PintoDepartment of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom.
Sierra N SparksDepartment of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom.
Congxiyu WangDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Sana SuriDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Daniel P BulteDepartment of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular smooth muscle cells (VSMCs) are the key moderators of cerebrovascular dynamics in response to the brain's oxygen and nutrient demands. Crucially, VSMCs may provide a sensitive biomarker for neurodegenerative pathologies where vasculature is compromised. An increasing body of research suggests that VSMCs have remarkable plasticity and their pathophysiology may play a key role in the complex process of neurodegeneration. Furthermore, extrinsic risk factors, including environmental conditions and traumatic events can impact vascular function through changes in VSMC morphology. VSMC dysfunction can be characterised at the molecular level both preclinically, and clinically

Indexed as

Alzheimer’s diseasecerebral blood flowcerebrovascular reactivitydementiaMRIneurodegenerationvascular smooth muscle cells

Identifiers

PMID36440263
PMCPMC9684644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.